Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
JournalTransplantation
Volume91
Issue number1
DOIs
StatePublished - Jan 15 2011

Fingerprint

Ganciclovir
Acyclovir
Cytomegalovirus Infections
Cytomegalovirus
Liver Transplantation
Antiviral Agents
Guidelines
Liver
valganciclovir

ASJC Scopus subject areas

  • Transplantation

Cite this

@article{cbfdeea02e84430c8c7e4c028226027d,
title = "Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines",
author = "Kalil, {Andre C} and Florescu, {Diana F}",
year = "2011",
month = "1",
day = "15",
doi = "10.1097/TP.0b013e3181fc8921",
language = "English (US)",
volume = "91",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines

AU - Kalil, Andre C

AU - Florescu, Diana F

PY - 2011/1/15

Y1 - 2011/1/15

UR - http://www.scopus.com/inward/record.url?scp=78751666353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751666353&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3181fc8921

DO - 10.1097/TP.0b013e3181fc8921

M3 - Letter

VL - 91

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -